CHARM Therapeutics

A 3D deep-learning research company that discovers and develops medicines for diseases such as cancer.

CHARM Therapeutics utilizes its proprietary DragonFold platform, which is based on protein-ligand co-folding, to identify novel molecules for drug discovery. The company has a strategic focus on creating small-molecule drugs. The business model appears to be centered on leveraging its advanced AI-driven technology to accelerate the drug discovery process, potentially entering into collaborations and partnerships with larger pharmaceutical companies, as evidenced by their collaboration with Bristol Myers Squibb. The company has raised a total of $70 million in funding to date, which supports its research and development activities. The primary clients and beneficiaries of CHARM's work would be patients in need of new treatments, and their partners in the pharmaceutical industry.

Keywords: 3D deep-learning, drug discovery, oncology, small-molecule drugs, protein-ligand co-folding, DragonFold, pharmaceutical collaborations, medical research, biotechnology, computational chemistry